Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document from the society for cardiovascular angiography and interventions (SCAI)

Journal of the American College of Cardiology

Volumn 62, Issue 17, 2013, Pages 1563-1570

  Moussa, Issam D ^a   Klein, Lloyd W ^b   Shah, Binita ^c   Mehran, Roxana ^d   Mack, Michael J ^e   Brilakis, Emmanouil S ^f   Reilly, John P ^g   Zoghbi, Gilbert ^h   Holper, Elizabeth ⁱ   Stone, Gregg W ^j  

^a MAYO CLINIC   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e BAYLOR HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g Oschner Clinic   (United States)

^h Department of Cardiology   (United States)

ⁱ MEDICAL CITY DALLAS HOSPITAL   (United States)

^j Department of Medicine   (United States)

more..

Author keywords

cardiac biomarkers; coronary revascularization; myocardial infarction definition

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; TROPONIN;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CALCIFICATION; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MORTALITY; PATHOPHYSIOLOGY; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK BENEFIT ANALYSIS; THROMBUS;

EID: 84886003933     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.720     Document Type: Review

References (99)

1. S. Leonardi, P.W. Armstrong, and P.J. Schulte Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: A systematic review Eur Heart J 34 2013 894 902
2. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
3. K. Thygesen, J.S. Alpert, and S. Allan Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
4. C.C. Lim, F. Cuculi, and W.J. van Gaal Early diagnosis of perioperative myocardial infarction after coronary bypass grafting: A study using biomarkers and cardiac magnetic resonance imaging Ann Thorac Surg 92 2011 2046 2053
5. X. Muschart, A. Slimani, and J. Jamart The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome J Invasive Cardiol 24 2012 655 660
6. T. Lee, T. Yonetsu, and K. Koura Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation Circ Cardiovasc Interv 4 2011 378 386
7. R. Mehran, G. Dangas, and G.S. Mintz Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary intervention: Intravascular ultrasound study of 2256 patients Circulation 101 2000 604 610
8. P.K. Kanaparti, and D.L. Brown Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention Am J Cardiol 86 2000 619 622
9. W.J. van Gaal, F.A. Ponnuthurai, and J. Selvanayagam The syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention Int J Cardiol 135 2009 60 65
10. S. Garg, G. Sarno, and C. Girasis A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials J Am Coll Cardiol Intv 4 2011 645 653
11. T. Palmerini, P. Genereux, and A. Caixeta Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Analysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial J Am Coll Cardiol 57 2011 2389 2397
12. D.E. Cutlip, and R.E. Kuntz Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes Circulation 112 2005 916 923
13. J.C. Blankenship, M.A. Islam, C.G. Wood, and E.A. Iliadis Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation Cath Cardiovasc Int 63 2004 31 41
14. A. Jeremias, D.S. Baim, and K.K. Ho Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures J Am Coll Cardiol 44 2004 1210 1214
15. A.J. Lansky, and G.W. Stone Periprocedural myocardial infarction. Prevalence, prognosis, and prevention Circ Cardiovasc Interv 3 2010 602 610
16. M. Panteghini A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins Clin Chem Lab Med 47 2009 1179 1182
17. A. Prasad, C.S. Rihal, and R.J. Lennon Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: An analysis of preintervention and postintervention troponin T levels in 5487 patients Circ Cardiovasc Interv 1 2008 10 19
18. A. Jeremias, N.S. Kleiman, and D. Nassif Evaluation of drug eluting stents and ischemic events (EVENT) registry investigators. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the evaluation of drug eluting stents and ischemic events registry Circulation 118 2008 632 638
19. M.P. Bonaca, S.D. Wiviott, and E. Braunwald Universal definition of myocardial infarction classification system and the risk of cardiovascular death: Observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38 Circulation 125 2012 577 583
20. A.S. Jaffe, J. Ravkilde, and R. Roberts It's time for a change to a troponin standard Circulation 102 2000 1216 1220
21. J.E. Adams III, G.S. Bodor, and V.G. Davila-Roman Cardiac troponin I. A marker with high specificity for cardiac injury Circulation 88 1993 101 106
22. V. Novack, M. Pencina, and D.J. Cohen Troponin criteria for myocardial infarction after percutaneous coronary intervention Arch Intern Med 172 2012 502 508
23. C.W. Hamm, E. Giannitsis, and H.A. Katus Cardiac troponin elevations in patients without acute coronary syndrome Circulation 106 2002 666 671
24. G.W. Stone, R. Mehran, and G. Dangas Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients Circulation 104 2001 642 647
25. S.J. Brener, S.G. Ellis, J. Schneider, and E.J. Topol Frequency and long-term impact of myonecrosis after coronary stenting Eur Heart J 23 2002 869 876
26. J.B. Lindsey, K.F. Kennedy, and J.M. Stolker Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: Results from the evaluation of drug-eluting stents and ischemic events (EVENT) registry Circ Cardiovasc Interv 4 2011 474 480
27. G.W. Stone, A. Rizvi, W. Newman SPIRIT IV investigators Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
28. P. Damman, L. Wallentin, and K.A. Fox Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: A collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR) Circulation 125 2012 568 576
29. M.J. Ricciardi, E. Wu, and C.J. Davidson Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation Circulation 103 2001 2780 2783
30. G. Rioufol, G. Finet, and I. Ginon Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study Circulation 106 2002 804 808
31. A. Tanaka, K. Shimada, and T. Sano Multiple plaque rupture and C-reactive protein in acute myocardial infarction J Am Coll Cardiol 45 2005 1594 1599
32. Z. Zhao, B. Witzenbichler, and G.S. Mintz Dynamic nature of nonculprit coronary artery lesion morphology in STEMI J Am Coll Cardiol Img 6 2013 86 95
33. I. Klem, D.J. Shah, and R.D. White Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: An international, multicenter study Circ Cardiovasc Imaging 4 2011 610 619
34. I. Porto, J.B. Selvanayagam, and W.J. Van Gaal Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: Insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound Circulation 114 2006 662 669
35. C.C. Lim, W.J. van Gaal, and L. Testa With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention J Am Coll Cardiol 57 2011 653 661
36. P. Eigel, G. van Ingen, and S. Wagenpfeil Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery Eur J Cardiothorac Surg 20 2001 544 549
37. J.B. Selvanayagam, S.E. Petersen, and J.M. Francis Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: A randomized trial using cardiovascular magnetic resonance imaging and biochemical markers Circulation 109 2004 345 350
38. K.W. Mahaffey, M.T. Roe, and R. Kilaru Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: Results from four large clinical trials Eur Heart J 28 2007 425 432
39. N. Nesher, A.A. Alghamdi, and S.K. Singh Troponin after cardiac surgery: a predictor or a phenomenon? Ann Thorac Surg 85 2008 1348 1354
40. D. Paparella, G. Cappabianca, and G. Visicchio Cardiac troponin I release after coronary artery bypass grafting operation: Effects on operative and midterm survival Ann Thorac Surg 80 2005 1758 1764
41. J. Ramsay, S. Shernan, and J. Fitch Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves J Thorac Cardiovasc Surg 129 2005 300 306
42. K. Klatte, B.R. Chaitman, and P. Theroux Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: Results from the GUARDIAN trial J Am Coll Cardiol 38 2001 1070 1077
43. M.A. Costa, R.G. Carere, and S.V. Lichtenstein Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS) Circulation 104 2001 2689 2693
44. B.L. Croal, G.S. Hillis, and P.H. Gibson Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery Circulation 114 2006 1468 1475
45. K. Vikenes, K.S. Andersen, and T. Melberg Long time prognostic value of CK-MB mass in low-risk patients with stable angina scheduled for cardiac surgery Cardiology 113 2009 122 131
46. G.A. Lurati Buse, M.T. Koller, and M. Grapow The prognostic value of troponin release after adult cardiac surgery - A meta-analysis Eur J Cardiothorac Surg 37 2010 399 406
47. Y. van Geene, H.A. van Swieten, and L. Noyez Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality J Thorac Cardiovasc Surg 10 2009 413 416
48. L. Petaja, M. Salmenpera, and K. Pulkki Biochemical injury markers and mortality after coronary artery bypass grafting: A systematic review Ann Thorac Surg 87 2009 1981 1992
49. M.J. Domanski, K. Mahaffey, and V. Hasselblad Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery JAMA 305 2011 585 591
50. W.J. Van Gall, J.R. Arnold, and L. Testa Myocardial injury following coronary artery surgery versus angioplasty (MICASA): A randomized trial using biochemical markers and cardiac magnetic resonance imaging EuroIntervention 6 2011 703 710
51. J. Steuer, T. Berner, and O. Duvernoy Visualization and quantification of perioperative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging Eur Heart J 25 2004 1293 1299
52. K. Rahimi, A.P. Banning, and A.S.H. Cheng Prognostic value of coronary revascularization-related myocardial injury: A cardiac magnetic resonance imaging study Heart 95 2009 1937 1943
53. A. Remppis, T. Scheffold, and J. Greten Intracellular compartmentation of troponin T: Release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart J Mol Cell Cardiol 27 1995 793 803
54. T.F. Fitzmaurice, C. Brown, and N. Rifai False increase of cardiac troponin I with heterophilic antibodies Clin Chem 44 1998 2212 2214
55. J. Krahn, D.M. Parry, and M. Leroux High percentage of false positive cardiac troponin I results in patients with rheumatoid factor Clin Biochem 32 1999 477 480
56. G.S. Bodor, L. Survant, and E.M. Voss Cardiac troponin T composition in normal and regenerating human skeletal muscle Clin Chem 43 1997 476 484
57. T.Y. Wang, E.D. Peterson, and D. Dai Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric J Am Coll Cardiol 51 2008 2068 2074
58. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 122
59. D.A. Morrow Clinical application of sensitive troponin assays N Engl J Med 361 2009 913 915
60. P. Venge, N. Johnston, and B. Lindahl Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia J Am Coll Cardiol 54 2009 1165 1172
61. T. Omland, J.A. de Lemos, and M.S. Sabatine A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med 361 2009 2538 2547
62. J.A. de Lemos, M.H. Drazner, and T. Omland Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population JAMA 304 2010 2503 2512
63. M.T. Roe, J.C. Messenger, and W.S. Weintraub Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention J Am Coll Cardiol 56 2010 254 263
64. D.O. Williams, R. Holubkov, and W. Yeh Percutaneous coronary intervention in the current era compared with 1985-1986: The national heart, lung, and blood institute registries Circulation 102 2000 2945
65. L.W. Klein, B.F. Uretsky, and C. Chambers Quality assessment and improvement in interventional cardiology. A position statement of the society of cardiovascular angiography and interventions. I. Standards for quality assessment and improvement in interventional cardiology Cath Cardiovasc Int 77 2011 927 935
66. K.M. Eggers, L. Lind, P. Venge, and B. Lindahl Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction? Am J Cardiol 103 2009 588 591
67. R.R. Brandt, K. Filzmaier, and P. Hanrath Circulating cardiac troponin I in acute pericarditis Am J Cardiol 87 2001 1326 1328
68. S.C. Smith, J.H. Ladenson, J.W. Mason, and A.S. Jaffe Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates Circulation 95 1997 163 168
69. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
70. S. Bangalore, S. Pursnani, S. Kumar, and P.G. Bagos Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease Circulation 127 2013 769 781
71. C.G. Gustavsson, O. Hansen, and B. Frennby Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury Scand Cardiovasc J 38 2004 75 79
72. W.L. Miller, K.N. Garratt, and M.F. Burritt Baseline troponin level: Key to understanding the importance of post-PCI troponin elevations Eur Heart J 27 2006 1061 1069
73. A. Kini, J.D. Marmur, and S. Kini Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention J Am Coll Cardiol 34 1999 663 671
74. M.K. Hong, R. Mehran, and G. Dangas Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality Circulation 100 1999 2400 2405
75. B.E. Tardiff, R.M. Califf, and J.E. Tcheng Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention: IMPACT-II J Am Coll Cardiol 33 1999 88 96
76. G. Dangas, R. Mehran, and D. Feldman Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention Am J Cardiol 89 2002 586 589
77. S.G. Ellis, D. Chew, and A. Chan Death following creatine kinase-MB elevation after coronary intervention: Identification of an early risk period: Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy Circulation 106 2002 1205 1210
78. J.P. Ioannidis, E. Karvouni, and D.G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J Am Coll Cardiol 42 2003 1406 1411
79. A.E. Ajani, R. Waksman, and A.K. Sharma Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis Am J Cardiol 93 2004 313 317
80. J.S. Jang, M.K. Hong, and D.W. Park Impact of periprocedural myonecrosis on clinical events after implantation of drug-eluting stents Int J Cardiol 129 2008 368 372
81. M. Andron, R.H. Stables, and M. Egred Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention J Invasive Cardiol 20 2008 108 112
82. E. Garbarz, B. Iung, and G. Lefevre Frequency and prognostic value of cardiac troponin I elevation after coronary stenting Am J Cardiol 84 1999 515 518
83. J.P. Bertinchant, A. Polge, and B. Ledermann Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris Am J Cardiol 84 1999 51 57
84. S. Fuchs, R. Kornowski, and R. Mehran Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions Am J Cardiol 85 2000 1077 1082
85. W.J. Cantor, L.K. Newby, and R.H. Christenson Prognostic significance of elevated troponin I after percutaneous coronary intervention J Am Coll Cardiol 39 2002 1738 1744
86. J. Herrmann, C. Von Birgelen, and M. Haude Prognostic implication of cardiac troponin T increase following stent implantation Heart 87 2002 549 553
87. B.K. Nallamothu, S. Chetcuti, and D. Mukherjee Prognostic implication of troponin I elevation after percutaneous coronary intervention Am J Cardiol 91 2003 1272 1274
88. J.R. Kizer, M.R. Muttrej, and W.H. Matthai Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention Eur Heart J 24 2003 1314 1322
89. M.K. Natarajan, C. Kreatsoulas, and J.L. Velianou Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions Am J Cardiol 93 2004 750 753
90. A.S. Kini, P. Lee, and J.D. Marmur Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality Am J Cardiol 93 2004 18 23
91. C. Cavallini, S. Savonitto, and R. Violini Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study Euro Heart J 26 2005 1494 1498
92. T. Nageh, R.A. Sherwood, B.M. Harris, and M.R. Thomas Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease Heart 91 2005 1181 1185
93. A. Prasad, M. Singh, and A. Lerman Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality J Am Coll Cardiol 48 2006 1765 1770
94. M.B. Nienhuis, J.P. Ottervanger, and H.J. Bilo Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis Cath Cardiovasc Interv 71 2008 318 324
95. J. Hubacek, R.S. Basran, and F.M. Shrive Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention Can J Cardiol 25 2009 e42 e47
96. A. De Labriolle, G. Lemesle, and L. Bonello Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery Am J Cardiol 103 2009 639 645
97. D.N. Feldman, R.M. Minutello, and G. Bergman Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes Am J Cardiol 104 2009 1210 1215
98. C. Cavallini, P. Verdecchia, and S. Savonitto Prognostic value of isolated troponin I elevation after percutaneous coronary intervention Circ Cardiovasc Interv 3 2010 431 435
99. D.N. Feldman, L. Kim, and A.G. Rene Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: A meta-analysis Cath Cardiovasc Interv 77 2011 1020 1030